Vivus inc (VVUS)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows from operating activities:
Net loss

-28,767

-31,503

-29,456

-27,607

-34,246

-36,950

-42,525

-39,296

-40,108

-30,511

36,127

32,969

34,954

23,302

-45,444

-52,398

-90,349

-93,107

-106,371

-106,090

-82,563

-82,647

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-174,946

-214,011

-206,108

-174,739

-139,733

-95,547

-63,883

-55,921

-47,026

0

0

0

-

-

-

-

Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Net loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Depreciation and amortization

14,697

14,702

14,702

14,730

12,393

8,875

5,352

1,805

716

811

913

1,017

1,041

1,080

1,131

1,220

1,293

1,387

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,003

973

820

636

432

271

141

93

91

102

0

0

0

-

-

-

-

Amortization of debt issuance costs and discounts

-4,015

-4,070

-231

5,467

11,764

18,228

20,669

21,175

20,921

20,442

19,969

19,496

19,066

18,666

18,273

17,896

17,529

17,174

16,851

16,538

16,536

15,923

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount or premium on available-for-sale securities

-

502

581

265

-322

-559

-801

-942

-644

-768

-849

-883

-936

-944

-1,042

-1,296

-1,697

-2,282

-3,001

-3,588

-3,943

-4,016

-3,774

-3,554

-3,036

-2,635

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

Share-based compensation expense

1,896

2,026

2,053

2,246

2,828

3,285

3,371

3,448

3,140

2,942

2,765

2,653

2,759

2,284

2,298

1,914

2,292

3,590

5,030

6,849

8,468

9,766

12,410

26,128

29,184

32,397

32,771

21,657

19,281

15,938

12,450

9,490

7,951

7,353

7,441

7,394

6,949

6,443

0

0

0

Unrealized foreign currency remeasurement gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Accounts receivable

1,004

-2,857

440

13,497

13,263

13,421

11,819

2,630

-152

2,709

1,511

-2,601

-412

481

-4,599

788

143

-2,598

-12,205

-3,030

-19,367

-619

20,510

8,199

26,201

9,436

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

15,843

12,623

10,638

10,318

1,369

5,849

7,546

4,869

3,816

1,526

2,183

4,819

5,766

2,584

2,031

1,203

4,826

8,487

455

-2,714

-9,110

-11,886

2,344

9,492

21,831

30,195

38,662

37,749

29,331

22,050

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-794

201

-996

374

96

370

3,998

1,064

1,941

-1,069

-1,800

-1,905

-1,152

-1,516

-3,234

-2,290

-5,895

-2,639

-1,364

-2,564

-5,282

-7,734

-13,588

-9,307

-10,551

-2,086

5,568

10,493

22,487

17,366

14,067

6,647

151

145

-1,598

-2,515

-526

-2,658

0

0

0

Accounts payable

7,400

-1,195

1,676

-545

-1,171

-1,151

53

-39

-121

5,365

-2,010

-3,816

-2,757

-2,353

-1,082

-6,793

-1,693

-3,370

-713

5,278

1,687

-329

-9,495

-7,103

-11,034

-14,821

4,725

10,134

13,462

22,202

10,732

23

3,217

545

-2,842

1,784

-3,998

-5,687

0

0

0

Accrued research and clinical expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Accrued employee compensation and benefits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Accrued and other liabilities

2,973

1,248

4,541

9,870

6,934

5,838

5,346

-1,393

412

5,859

9,914

10,311

8,860

-1,524

-5,553

-5,015

-6,502

-889

-8,594

-7,508

-9,066

-9,061

2,805

7,301

12,265

13,170

11,344

6,814

7,746

7,385

3,564

2,251

1,021

15

-518

-305

982

1,197

0

0

0

Deferred revenue

-1,165

-1,213

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-1,279

-

-88,884

-19,330

-18,168

-3,027

66,871

-1,602

-1,363

329

-607

-1,043

-896

706

9,562

26,555

26,618

26,465

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used for operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-46,648

-

-47,224

-40,734

-24,610

-38,105

-46,075

-43,052

-98,119

-135,117

-179,744

-204,404

-180,235

-131,031

-80,230

-55,265

-38,682

-35,920

-42,864

-49,295

-60,846

-66,302

0

0

0

Net cash used for operating activities from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-208

-254

-756

-773

-885

-963

-797

-929

-980

709

694

-694

2,195

0

0

0

Net cash provided by (used for) operating activities

-23,420

-30,474

-20,023

-22,917

-18,559

-23,607

-31,540

-23,207

-21,280

-16,364

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-135,325

-179,998

-205,160

-181,008

-131,916

-81,193

-56,062

-39,611

-36,900

-42,155

-48,601

-61,540

-64,107

0

0

0

Investing activities:
Fixed asset purchases

-

42

42

39

21

34

34

34

34

21

0

0

0

-

-

-

-

310

372

243

292

262

200

145

883

1,795

0

0

0

-

-

-

-

-

-

-

-

105

0

0

0

Purchases of available-for-sale securities

-

16,879

50,781

50,781

47,778

41,506

17,786

17,786

17,786

31,097

106,389

124,389

126,489

135,997

87,549

121,488

196,471

213,536

229,134

246,771

237,118

240,983

0

0

0

-

-

-

-

226,654

279,036

262,930

155,346

137,409

0

0

0

-

-

-

-

Other non-current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds from maturity of available-for-sale securities

-

42,087

51,832

45,925

42,650

58,101

56,706

54,761

53,572

37,470

29,120

45,720

43,284

60,050

121,800

166,950

235,500

281,250

278,250

283,250

271,250

260,500

0

0

0

-

-

-

-

-

-

104,000

108,780

129,000

0

0

0

-

-

-

-

Proceeds from sales of available-for-sale securities

-

56,403

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of available-for-sale securities

-

-

-

-

-

-

-

-

23,133

-

42,533

39,585

33,234

36,080

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Proceeds from maturities of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,362

3,572

1,699

3,050

1,681

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Investment purchases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Proceeds from sale/maturity of securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net cash (used for) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42,432

-

48,692

33,120

32,552

15,893

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

63,223

0

0

0

Net cash provided by investing activities from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,546

0

0

0

Net cash used for investing activities

-

81,569

58,035

-2,048

-83,591

-56,150

-30,201

-27,348

58,885

24,012

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-133,726

-140,020

-38,019

-8,610

63,557

88,933

101,432

84,769

0

0

0

Financing activities:
Repayments of notes payable

-

-

-

-

-

64,334

61,494

76,757

28,591

26,077

24,149

11,076

8,615

8,738

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments of financing leases

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from exercise of common stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

4,589

13,250

13,514

11,226

9,479

2,354

3,319

4,334

4,378

3,617

0

0

0

Repayments of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sale of common stock through employee stock purchase plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

192,000

0

0

0

-

-

-

-

-

-

-

-

Net cash used for financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,971

-

-5,135

-2,282

1,287

2,124

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-19,079

0

0

0

Net cash used for financing activities from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,900

0

0

0

Net cash used for financing activities

0

-

-

-

-

43,776

46,612

31,330

-28,553

-26,039

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

205,714

248,710

246,978

47,848

21,041

-23,267

-23,178

-23,979

0

0

0

Effect of exchange rates on cash and cash equivalents

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

9,052

-

-80,986

-6,139

-15,948

-10,612

74,641

-3,821

-15,187

12,221

-3,667

-9,896

9,229

-20,088

-59,958

-28,451

-947

44,657

80,847

43,773

-110,076

19,051

-9,205

52,628

169,348

2,338

42,443

17,065

16,714

-3,317

0

0

0